The global colposcopy market size is expected to reach USD 761.2 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.8% from 2022 to 2030. Increase in the prevalence of cervical cancer, technological advancements, and the rising demand for early- diagnosis of gynecological disorders are expected to boost the market growth. According to the ICO Information Centre on HPV and Cancer, cervical cancer is the fourth most frequent cancer among women globally, with an estimated 604,127 new cases and 341,831 deaths in 2020.
Colposcopy Market Report Highlights
- The optical colposcopy segment dominated the market and is further expected to continue its dominance over the forecast period, as the adoption of optical colposcope is high in developing regions
- The video colposcopy segment is expected to grow at the fastest rate during the forecast period
- Based on application, the oral examination segment is expected to grow the fastest rate during the forecast period and also held the largest revenue share in 2021
- Based on portability, the handheld segment is estimated to register the fastest growth rate during the forecast period, owing to its ease of use and compact nature
- The hospital segment held the largest revenue share based on end-use in 2021
- North America dominated the market and accounted for the largest revenue share in 2021
- In Asia Pacific, the market is anticipated to witness the fastest CAGR over the forecast period owing to the growing need for technologically advanced and cost-effective healthcare solutions
Gain deeper insights on the market and receive your free copy with TOC now @: Colposcopy Market Report
Colposcopy is a test to take a closer look at cervix, vagina & vulva using a colposcope (A lighted, magnifying instrument) for signs of cancerous or pre-cancerous tissue. An article published by the Human Papillomavirus Information Center stated that cervical cancer is reported to be the second most common cancer among women aged 15 to 44. Colposcopy helps in accurate identification of cervical pre-cancer and early invasive cancer. Moreover, colposcope directed biopsies of severe lesion visualized help in further management of the disease. Growing awareness and rise in the number of screening campaigns for cervical cancer conducted by governments of various regions are expected to fuel the market growth during the forecast period.
In the U.S., National Breast and Cervical Cancer Early Detection Program (NBCCEDP) offers breast and cervical cancer screening and diagnostic services to low-income, uninsured, and underinsured women across the country. It is estimated that due to COVID-19, screenings for cancers of the breast, colon, and cervix have dropped by 94%, 86%, & 94% in 2020. Coronavirus pandemic had a substantial effect on women’s access to care, where nearly two-thirds of women were delayed or not adherent to care. Several obstacles arose as a result of the COVID-19 pandemic, including logistical constraints, low demand, and reduced sales and marketing activities. However, by mid-2022, the market is predicted to be steadily improving. By encouraging end-users to embrace high-end technologies for early diagnosis of the disease, aiming to lessen cervical cancer cases by 70%, and thus preventing over 4.5 million deaths (Source: WHO). This is expected to significantly boost the market in the coming years.
Colposcopy Market Insights By Geographical Regions:
North America dominated the colposcopy market with the largest revenue share of 31.0%, owing to an increase in the prevalence of cervical cancer and a rise in healthcare expenditure. Factors such as the adoption of colposcopy equipment, easy access to healthcare technologies, and the presence of significant distribution channels are expected to boost the market growth. In Asia Pacific, the market is estimated to witness the fastest CAGR during the forecast period owing to the presence of a large patient pool and the growing need for technologically advanced and cost-effective healthcare solutions.
Market Share Insights By Key Players:
The key players are developing advanced colposcopes to meet the growing prevalence of cervical cancer. Moreover, regional and service portfolio expansions and mergers and acquisitions are key strategies adopted by these players. Some of the prominent players in the colposcopy market include:
- Kaps GmbH & Co. KG
- Carl Zeiss Meditec AG
- CooperSurgical, Inc
- DYSIS Medical Inc
- ATMOS Medizin Technik GmbH & Co. KG
- Olympus Corporation
For Any Questions or Inquire please visit @: https://www.grandviewresearch.com/industry-analysis/colposcopy-market/request/rs5
Colposcopy Market Segmentation
Grand View Research has segmented the global colposcopy market based on modality, application, portability, end-use, and region:
Modality Outlook
- Optical
- Video
Application Outlook
- Pelvic
- Oral
Portability Outlook
- Handheld
- Stationary
End-use Outlook
- Hospitals
- Diagnostic centres
- Gynaecology clinic
- Specialty clinics
- Ambulatory surgical centre
- Research and academics
Regional Outlook
- North America
- U.S.; Canada
- Europe
- U.K.; Germany; France; Italy; Spain
- Asia Pacific
- Japan; China; India; South Korea
- Latin America
- Brazil; Mexico; Argentina
- Middle East and Africa
- South Africa; Saudi Arabia; UAE
Research Methodology
We employs a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. We utilizes a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Raw market data is obtained and collated on a broad front. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
For Customized reports or Special Pricing please visit @: https://www.grandviewresearch.com/special-pricing/5364/rfsp2
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com